Intraductal photodynamic therapy and its combination with intra-arterial chemoinfusion in the treatment of inoperable patients with Klatskin tumor
- Authors: Kozlov A.V.1, Polikarpov A.A.1, Tarazov P.G.1, Moiseenko A.V.1, Jutkin M.V.1, Shapoval S.V.1, Turlak A.S.1, Granov D.A.1
-
Affiliations:
- Granov Russian Research Center of Radiology and Surgical Technologies
- Issue: Vol 14, No 1 (2023)
- Pages: 84-94
- Section: Original Study Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/142808
- DOI: https://doi.org/10.17816/clinpract114961
- ID: 142808
Cite item
Full Text
Abstract
Background: A palliative or symptomatic treatment is indicated for 70–80% of patients with Klatskin’s tumor because of the advanced lesion volume and the patient’s grave condition. Hepatic arterial infusion chemotherapy, chemoembolization, radioembolization are successfully used in the treatment of hepatocellular carcinoma and liver metastases.
Aim: to estimate the immediate and long-term results of photodynamic therapy (PDT) and its combination with hepatic arterial infusion in inoperable patients with Klatskin tumors.
Methods: Between 2010 and 2021, 83 palliative PDT sessions (from 1 to 8, average 2.4) were performed in 82 patients as a single treatment or in combination with hepatic arterial infusion. In all cases, percutaneous transhepatic biliary drainage was previously performed; no chemotherapy was applied. Two groups of 48 patients were stratified according to the ECOG status (2–3) and the numbers of PDT sessions (no more than two). The treatment group of the combination therapy consisted of 24 patients (13 male, 11 female) aged 38 to 85 (mean 63) years with the ECOG status of 2–4 (mean 2.4). This group received PDT with hepatic arterial infusion using a GemCis regimen. On average, 1.4 PDT sessions were performed, the treatment started on the 89th (27–225) day after the biliary drainage. The hepatic arterial infusion was performed on the 2d–3th day after the PDT. The control group received only PDT and consisted of 24 patients (13 male, 11 female) aged 51 to 83 (66 on average) years, with the ECOG status of 2–3 (mean 2.6). On average, 1.4 PDT sessions were performed, starting on the 106th (32–405) day after the biliary drainage.
Results: There were no serious adverse events associated with PDT in both groups. Toxic complications of hepatic arterial infusion were observed in 13 of 24 patients (54%): I–II grade hematological (54%) and gastrointestinal (69%); all were eliminated with medical therapy. Complications of the percutaneous transhepatic biliary drainage in three patients (hemobilia, n=2, and sepsis, n=1) were estimated as grade III by the CIRSE classification (2017) and successfully treated without surgery. In the combination treatment group, the overall mean survival and median survival were higher than those in the control group: 327.9±39.8 days (10.9 mo) versus 246.9±31.2 days (8.2 mo) and 275 days versus 244 days. However, these differences did not reach the statistical significance (p=0.12).
Conclusions: PDT is a safe method of a palliative treatment of critically ill patients with Klatskin tumor (ECOG 2–3). PDT alone has limited clinical efficacy. A combination of PDT and hepatic arterial infusion does not cause serious complications and may increase the survival rates.
Full Text
##article.viewOnOriginalSite##About the authors
Alexey V. Kozlov
Granov Russian Research Center of Radiology and Surgical Technologies
Author for correspondence.
Email: av_kozlov@mail.ru
ORCID iD: 0000-0002-6878-6762
SPIN-code: 3790-3030
MD, PhD
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgAleksey A. Polikarpov
Granov Russian Research Center of Radiology and Surgical Technologies
Email: pol1110@mail.ru
ORCID iD: 0000-0002-7683-5042
SPIN-code: 4641-0720
MD, PhD
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgPavel G. Tarazov
Granov Russian Research Center of Radiology and Surgical Technologies
Email: tarazovp@mail.ru
ORCID iD: 0000-0001-9190-116X
SPIN-code: 7089-7542
MD, PhD, Professor
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgAndrey V. Moiseenko
Granov Russian Research Center of Radiology and Surgical Technologies
Email: med_moiseenko@mail.ru
ORCID iD: 0000-0002-1011-4533
SPIN-code: 5992-9441
MD
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgMaksim V. Jutkin
Granov Russian Research Center of Radiology and Surgical Technologies
Email: yutkin-m@mail.ru
ORCID iD: 0000-0002-4566-1190
SPIN-code: 3767-4655
MD
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgSergey V. Shapoval
Granov Russian Research Center of Radiology and Surgical Technologies
Email: gotina@yandex.ru
ORCID iD: 0000-0002-3743-393X
SPIN-code: 9735-2998
MD, PhD
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgAnastasia S. Turlak
Granov Russian Research Center of Radiology and Surgical Technologies
Email: a_turlak18@mail.ru
ORCID iD: 0000-0002-2207-767X
SPIN-code: 8389-1364
MD
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgDmitrii A. Granov
Granov Russian Research Center of Radiology and Surgical Technologies
Email: dmitriigranov@gmail.com
ORCID iD: 0000-0002-8746-8452
SPIN-code: 5256-2744
MD, PhD, Professor, Academician of the Russian Academy of Sciences
Russian Federation, 70 Leningradskaya street, Pesochny, 197758 Saint PetersburgReferences
- Алиева С.Б., Базин И.С., Бредер В.В., и др. Клинические рекомендации. Рак желчевыводящей системы. Москва, 2020. 51 с. [Alieva SB, Bazin IS, Breder VV, et al. Clinical recommendations. Cancer of the biliary system. Moscow; 2020. 51 р. (In Russ).]
- Inchingolo R, Acquafredda F, Ferraro V, et al. Non-surgical treatment of hilar cholangiocarcinoma. World J Gastrointest Oncol. 2021;13(11):1696–1708. doi: 10.4251/wjgo.v13.i11.1696
- Францев Д.Ю., Сергеева О.Н., Долгушин Б.И. Лечение гилюсной холангиокарциномы. Современное состояние вопроса // Сибирский онкологический журнал. 2019. Т. 18, № 1. С. 103–115. [Frantsev DY, Sergeeva ON, Dolgushin BI. Treatment of hylus cholangiocarcinoma. The current state of the issue. Siberian Oncol J. 2019;18(1):103–115. (In Russ).] doi: 10.21294/1814-4861-2019-18-1-103-115
- Chen P, Yang T, Shi P, et al. Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis. Photodiagnosis Photodyn Ther. 2022;(37):102712. doi: 10.1016/j.pdpdt.2022.102712
- Таразов П.Г., Кагачева Т.И. Рентгеноэндоваскулярные вмешательства в лечении внутрипеченочной холангиокарциномы (обзор литературы) // Диагностическая и интервенционная радиология. 2021. Т. 15, № 3. С. 55–66. [Tarazov PG, Kalacheva TI. X-ray endovascular interventions in the treatment of intrahepatic cholangiocarcinoma (literature review). Diagnostic interventional radiology. 2021;15(3):55–66. (In Russ).] doi: 10.25512/DIR.2021.15.3.06
- Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):96–100. doi: 10.1002/jhbp.519
- Filippiadis DK, Binkert C, Pellerin O, et al. CIRSE quality assurance document and standards for classification of complications: the CIRSE classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–1146. doi: 10.1007/s00270-017-1703-4
- Гранов Д.А., Поликарпов А.А., Таразов П.Г., и др. Опухоль Клацкина, осложненная механической желтухой и холангитом, в реальной практике: нерезектабельная опухоль или инкурабельный пациент? // Вестник хирургии им. И.И. Грекова. 2020. Т. 179, № 4. С. 9–16. [Granov DA, Polikarpov AA, Tarazov PG, et al. Klatskin’s tumor, complicated by mechanical jaundice and cholangitis, in real practice: an unresectable tumor or an incurable patient? Bulletin Surgery named after I.I. Grekov. 2020;179(4):9–16. (In Russ).] doi: 10.24884/0042-4625-2020-179-4-9-16
- Khan J, Ullah A, Matolo N, et al. Klatskin tumor in the light of ICD-O-3: A population-based clinical outcome study involving 1,144 patients from the surveillance, epidemiology, and end result (SEER) database (2001–2012). Cureus. 2021;13(10):e18941. doi: 10.7759/cureus.18941
- Bisello S, Buwenge M, Palloni A, et al. Radiotherapy or chemoradiation in unresectable biliary cancer: A retrospective study. Anticancer Res. 2019;39(6):3095–3100. doi: 10.21873/anticanres.13445
- Wentrup R, Winkelmann N, Mitroshkin A, et al. Photodynamic therapy plus chemotherapy compared with photodynamic therapy alone in hilar nonresectable cholangiocarcinoma. Gut Liver. 2016;10(3):470–475. doi: 10.5009/gnl15175
- Li Z, Jiang X, Xiao H, et al. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma. Surg Endosc. 2021;35(10):5655–5664. doi: 10.1007/s00464-020-08095-1
- Lee TY, Cheon YK, Shim CS. Photodynamic therapy in patients with advanced hilar cholangiocarcinoma: Percutaneous cholangioscopic versus peroral transpapillary approach. Photomed Laser Surg. 2016;34(4):50–56. doi: 10.1089/pho.2015.3989
- Долгушин Б.И., Сергеева О.Н., Францев Д.Ю., и др. Внутрипротоковая фотодинамическая терапия при воротной холангиокарциноме у неоперабельных больных // Анналы хирургической гепатологии. 2016. Т. 21, № 3. C. 106–118. [Dolgushin BI, Sergeeva ON, Frantsev DY, et al. Intra-current photodynamic therapy in portal cholangiocarcinoma in inoperable patients. Annals surgical hepatology. 2016;21(3): 106–118. (In Russ).]
- Desai GS, Pande PM. Gastroduodenal artery: Single key for many locks. J Hepatobiliary Pancreat Sci. 2019;26(7):281–291. doi: 10.1002/jhbp.636
- Morell CM, Fabris L, Strazzabosco M. Vascular biology of the biliary epithelium. J Gastroenterol Hepatol. 2013;28(Suppl 1): 26–32. doi: 10.1111/jgh.12022
- Sinn M, Nicolaou A, Gebauer B, et al. Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: A phase II study. Dig Dis Sci. 2013;58(8):2399–2405. doi: 10.1007/s10620-013-2624-y
- Wang X, Hu J, Cao G, et al. Phase II study of hepatic arterial infusion chemotherapy with oxaliplatin and 5-fluorouracil for advanced perihilar cholangiocarcinoma. Radiology. 2017; 283(2):580–589. doi: 10.1148/radiol.2016160572
- Козлов А.В., Таразов П.Г., Поликарпов А.А., и др. Артериальная химиоинфузия в лечении неоперабельных больных опухолью Клацкина: предварительные результаты // Клиническая практика. 2022. Т. 13, № 3. C. 25–31. [Kozlov AV, Tarazov PG, Polikarpov AA, et al. Arterial chemoinfusion in the treatment of inoperable patients with Klatskin’s tumor: Preliminary results. Journal of Clinical Practice. 2022;13(3): 25–31. (In Russ).] doi: 10.17816/clinpract109310